THIRST, NCT00851630: Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial |
|
|
| Completed | 4 | 70 | RoW | Fixed dose combination zidovudine/lamivudine/abacavir, Trizivir | Duke University, Kilimanjaro Christian Medical Centre, Tanzania, Kibongoto National Tuberculosis Hospital, Tanzania, GlaxoSmithKline | HIV, Tuberculosis | 09/07 | 09/07 | | |
